Evidence map›Paper›PMID 37493336›Full record

ArticleCancer biology & medicine2023

Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA.

Kenan Zhang, Xing Liu, Guanzhang Li, Xin Chang, Shouwei Li, Jing Chen, Zheng Zhao, Jiguang Wang, Tao Jiang, Ruichao Chai

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer biology & medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Kenan ZhangDepartment of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.
Xing LiuDepartment of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.
Guanzhang LiDepartment of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.
Xin ChangDepartment of Neurosurgery, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing 100093, China.
Shouwei LiDepartment of Neurosurgery, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing 100093, China.
Jing ChenDepartment of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.
Zheng ZhaoDepartment of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.
Jiguang WangDivision of Life Science and State Key Laboratory of Molecular Neuroscience, Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR 999077, China.
Tao JiangDepartment of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.
Ruichao ChaiDepartment of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37493336
PMCPMC10466440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.